MAKENNA LONG: Open Payments
NPI 1750115515 · CENTENNIAL, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,527 in 24 payments from 12 companies in 2025. Trend: 2023 $0 · 2024 $262 · 2025 $1,527
Travel & lodging: $1,022Food & beverage: $505
| Company | Payments | Amount |
|---|---|---|
| Chiesi USA, Inc. | 1 | $1,022 |
| Cycle Pharmaceuticals Inc | 6 | $136 |
| CSL Behring | 3 | $68 |
| GENZYME CORPORATION | 3 | $55 |
| Grifols USA, LLC | 2 | $50 |
| SOBI, INC | 1 | $38 |
| AstraZeneca Pharmaceuticals LP | 2 | $36 |
| Novartis Pharmaceuticals Corporation | 2 | $31 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $28 |
| ARS Pharmaceuticals Operations, Inc. | 1 | $24 |
Products named: Sajazir, DUPIXENT, Hizentra, Gamifant, TAKHZYRO, Xembify, NEFFY, Prolastin-C Liquid.
Industry payments across CO — which companies pay providers there.
